News

New Edition of the ‘Go-To’ Book on Diabetes Available

A “one-stop resource” for crucial scientific information on diabetes and its complications, last published in 1995, is out now in its third edition.


 

Diabetes in America was written to serve as the go-to book for anything you ever wanted to know about diabetes,” says Catherine Cowie, PhD, editor and senior advisor for the National Institute of Diabetes and Digestive and Kidney Diseases’ Diabetes Epidemiology Program. “It’s a resource for everyone, because diabetes affects just about everyone.”

[embed:render:related:node:148880]

Written by recognized experts who “represent every facet of diabetes,” the book covers relevant research, data and trends, complications and related conditions, and prevention and medical care. It is “rich in data,” says Dr. Cowie, and includes cross-sectional national data, as well as smaller geographic community and longitudinal studies. This edition includes both published and unpublished data that were specifically analyzed for the book.

Clinical trial data are summarized to show the strongest evidence available for the effectiveness of interventions, but the book also emphasizes “points of hope” found through research: For example, people at high risk can prevent or delay type 2 diabetes by losing a modest amount of weight, and rates of some complications, such as lower extremity amputations, are on the decline.

Cowie says Diabetes in America is designed to be useful to a variety of readers. Patients can use it to better understand their condition or risk factors; practitioners can use it to assess patients’ risk of diabetes and associated complications; health policy makers who need “sound quantitative knowledge” can use it to guide decision making; scientists can use it to help identify areas of needed research.

To download, visit: https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition.

Recommended Reading

Diabetes Mellitus Federal Health Data Trends (FULL)
Federal Practitioner
The Effects of Ranolazine on Hemoglobin A1c in a Veteran Population
Federal Practitioner
Diabetic Ketoacidosis Takes a Turn for the Worse
Federal Practitioner
How to Manage Diabetes While Keeping Costs Down
Federal Practitioner
Risks vs Benefits for SGLT2 Inhibitor Medications
Federal Practitioner
Analysis shows ‘Devil’s bargain’ in cardiac arrest
Federal Practitioner
Metformin and Long-Acting Insulin Don’t Help Slow Diabetes in Young People
Federal Practitioner
Studies support cardiovascular risk management in T2DM
Federal Practitioner
CDC: Obesity affects over 35% in 7 states
Federal Practitioner
Study suggests “alarming” diabetes med discontinuation
Federal Practitioner